300+ investors in your industry, stage, and region Get
Any industry
Google
Clean Energy
EdTech
Artificial Intelligence
Local
Enterprise Software
Travel
Platforms
InsurTech
Oil and Gas
Retail
Social Impact
Cryptocurrency
SaaS
Film
Restaurants
Photography
Email
CleanTech
Payments
Energy
Marketplace
Fitness
Organic Food
Machine Learning
Health Care
Gaming
Agriculture (AgTech)
Facebook
Social Network
Blockchain
B2B
Video Games
Big Data
Medical Device
Wellness
Mobile
Automotive
Sports
Education
Hospitality
Biotechnology
Consumer
Software
Renewable Energy
Crowdfunding
Theatre
Medical
Recruiting
Legal
eSports
Construction
Web3
Venture Capital
Fashion
Cannabis
Social
Beauty
LGBT
Celebrity
Infrastructure
Mobile Apps
Life Science
Climate
Wine and Spirits
Music
Food and Beverage
Publishing
Manufacturing
Digital Media
Art
Real Estate
Sporting Goods
Financial Services
FinTech
Finance
Franchise
Mobile Advertising
Social Media
Non Profit
Android
Sustainability
Hardware
Biotech
Internet
Enterprise
Community
Impact
Media (Entertainment)
Proptech
Transportation
Any country
Hong Kong
Thailand
United Arab Emirates
Egypt
Greece
Croatia
Burkina Faso
South Korea
Singapore
Brazil
Kyrgyzstan
LATAM
Africa
Gibraltar
Liberia
Oceania
Taiwan
Mexico
Tunisia
Sweden
Zimbabwe
Zambia
Nigeria
Norway
Tajikistan
Russian Federation
Togo
Guinea
Nepal
Iran
Isle of Man
Madagascar
Romania
Pakistan
Oman
Puerto Rico
Poland
Cameroon
Guernsey
Andorra
Colombia
Sudan
Kenya
China
Armenia
Costa Rica
Czech Republic
Kuwait
Marshall Islands
Malta
Luxembourg
Mozambique
Namibia
Mauritius
Nicaragua
Panama
Serbia
New Zealand
Uzbekistan
Australia
Saudi Arabia
Sri Lanka
Jamaica
Switzerland
Guatemala
Morocco
Kazakhstan
Cayman Islands
Venezuela
Malawi
Myanmar
Turkey
Uruguay
Uganda
Seychelles
Moldova
Botswana
Paraguay
Japan
Ireland
Canada
United Kingdom
South Africa
Georgia
France
Ghana
Denmark
Iraq
Malaysia
Mali
Latvia
Portugal
Philippines
Sierra Leone
Rwanda
El Salvador
Senegal
Tanzania
United States
Germany
India
Indonesia
Middle East
Dominican Republic
Bermuda
Asia
Albania
Spain
Angola
Europe
Argentina
Cyprus
Qatar
Belgium
Barbados
Jordan
Bangladesh
Austria
Ethiopia
Azerbaijan
Bulgaria
Ecuador
Bahamas
Bolivia
Faroe Islands
Estonia
Algeria
Jersey
Bahrain
Finland
Italy
Belarus
Belize
Hungary
Grenada
Israel
Iceland
Liechtenstein
Lebanon
Mongolia
Cambodia
Honduras
Lithuania
Peru
Slovenia
San Marino
Ukraine
Vietnam
Chile
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Biotechnology VC Funds & Investors in South Korea (August 2026)

The most active venture capital funds investing in South Korea Biotechnology startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in South Korea Biotechnology startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Dayli Partners
VC Fund
30 South Korea, United States, Indonesia Series A, Series B, Seed Biotechnology, Health Care, Medical $791k–$29M
KB Investment
VC Fund
20 South Korea, United States, Vietnam Series A, Series B, Seed Software, Artificial Intelligence, Biotechnology $767k–$36M
Company K Partners
VC Fund
18 South Korea, United States, Singapore Series A, Series B Biotechnology, Health Care, Artificial Intelligence $2.2M–$42M
Industrial Bank of Korea
VC Fund
16 South Korea, United States, China Series A, Series B, Seed Software, Artificial Intelligence, Information Technology $166k–$28M
Korea Investment Partners
VC Fund
14 South Korea, United States, China Series A, Series B, Seed Biotechnology, Information Technology, Health Care $1.2M–$52M
Mirae Asset Venture Investment
VC Fund
12 South Korea, United States, India Series A, Series B, Seed Software, Artificial Intelligence, Biotechnology $924k–$54M
Aju IB Investment
VC Fund
12 South Korea, United States, Japan Series A, Series B, Series C Biotechnology, Health Care, Therapeutics
LSK Investment
VC Fund
12 South Korea, United States Series A, Series B, Series C Biotechnology, Medical, Health Care $1.6M–$46M
Kolon Investment
VC Fund
11 South Korea, India, Indonesia Series A, Series B Biotechnology, Software, Information Technology $6k–$24M
UTC Investment Co.
VC Fund
11 South Korea, United States, Japan Series A, Series B Biotechnology, Health Care, Medical $2.3M–$21M
Partners Investment
VC Fund
11 South Korea, United States, Japan Series A, Series B, Series C Biotechnology, Health Care, Software $2.5M–$98M
Medytox Venture Investment
VC Fund
11 South Korea Series A, Series B, Seed Biotechnology, Pharmaceutical, Medical $4k–$44M
InfoBank
VC Fund
11 South Korea, South Africa, United States Seed, Series A, Series B Artificial Intelligence, Information Technology, Software $100k–$16M
STIC Ventures
VC Fund
10 South Korea, United States, Vietnam Series A, Series B Biotechnology, Artificial Intelligence, Information Technology $2M–$47M
Devsisters Ventures
VC Fund
10 South Korea, United States, Russian Federation Series A, Seed Software, Biotechnology, Gaming $1k–$8.2M
Series Ventures
VC Fund
9 South Korea, Singapore Seed, Series A, Venture - Series Unknown Health Care, Manufacturing, Biotechnology $86k–$4.4M
Future Science and Technology Holdings
VC Fund
9 South Korea, United States Seed, Series A Biotechnology, Health Care, Food and Beverage $223k–$6.7M
Magna Investment
VC Fund
9 South Korea, United States, Japan Seed, Series A, Series B Health Care, Biotechnology, Pharmaceutical $147k–$18M
Enlight Ventures
VC Fund
9 South Korea, Indonesia Seed, Series A, Series B Manufacturing, Information Technology, Artificial Intelligence $392k–$20M
KB Securities
VC Fund
8 South Korea, United States, China Series B, Series A, Venture - Series Unknown Software, Health Care, Information Technology $2.4M–$27M
Shinhan Capital
VC Fund
8 South Korea, United States, India Series A, Seed, Series B Information Technology, Software, E-Commerce $347k–$18M
HB Investment
VC Fund
8 South Korea, United States, Vietnam Series B, Series A Software, Biotechnology, Artificial Intelligence $1.5M–$25M
SJ Investment Partners
VC Fund
8 South Korea, United States, Hong Kong Series A, Series B, Seed Biotechnology, Manufacturing, Medical $547k–$28M
Timewise Investment
VC Fund
7 South Korea, United States, Russian Federation Series A, Series B, Seed Biotechnology, Health Care, Information Technology $3k–$29M
HG Initiative
VC Fund
7 South Korea, United States Series A, Seed, Series B Biotechnology, Health Care, Medical $360k–$13M
Timepolio Asset Management
VC Fund
7 South Korea, United States, Russian Federation Series A, Series B, Series C Biotechnology, Health Care, Manufacturing $9k–$80M
BSK Investment
VC Fund
7 South Korea Series A, Series B, Series C Biotechnology, Software, Health Care $2.1M–$57M
Korea Technology Finance Corporation
VC Fund
7 South Korea, Russian Federation Seed, Series A, Series B Software, Manufacturing, Medical $7k–$15M
Korea Credit Guarantee Fund
VC Fund
7 South Korea, United States, China Seed, Series A, Venture - Series Unknown Artificial Intelligence, Information Technology, Software $198k–$15M
Stick Ventures
VC Fund
7 South Korea, United States Series B, Series A, Series C Biotechnology, Artificial Intelligence, Health Care $2.3M–$122M
Dt& Investment
VC Fund
7 South Korea, Vietnam, United States Series B, Series A, Seed Biotechnology, E-Commerce, Health Care $2k–$18M
IMM Investment
VC Fund
7 South Korea, United States, Japan Series A, Series B, Series C Health Care, Biotechnology, Artificial Intelligence $3M–$72M
Kiwoom Investment
VC Fund
7 South Korea, United States, Japan Series B, Series A, Series C Information Technology, Software, Artificial Intelligence $1.7M–$33M
Innopolis Partners
VC Fund
7 South Korea, United States, United Kingdom Series A, Seed Manufacturing, Health Care, Biotechnology $1k–$11M
ActnerLab
VC Fund
6 South Korea, United States, Japan Seed, Venture - Series Unknown Health Care, Medical, Medical Device $37k–$84k
Stonebridge Ventures
VC Fund
6 South Korea, United States, Japan Series B, Series A, Seed Artificial Intelligence, Biotechnology, Software $736k–$14M
Quad Asset Management
VC Fund
6 South Korea, United States Series B, Series A, Series C Biotechnology, Pharmaceutical, Medical $4.4M–$42M
Coolidge Corner Investment
VC Fund
6 South Korea, United States, Belgium Seed, Series A, Series B Software, Manufacturing, Health Care $223k–$11M
IBK Capital
VC Fund
6 South Korea, United States, India Series A, Seed, Series B Health Care, Biotechnology, Information Technology $2k–$22M
Pathfinder H
VC Fund
6 South Korea Series A, Series B, Seed E-Commerce, Biotechnology, Artificial Intelligence $775k–$21M
Hana Ventures
VC Fund
6 South Korea, United States, Peru Series A, Seed, Series B Software, Artificial Intelligence, Health Care $253k–$42M
POSCO CAPITAL
VC Fund
6 South Korea, United States Series A, Seed, Series B Software, Manufacturing, Information Technology $149k–$14M
Premier Partners
VC Fund
6 South Korea, United States, Russian Federation Series B, Series A Health Care, Biotechnology, Artificial Intelligence $2.5M–$45M
Atinum Partners
VC Fund
6 South Korea, United States, Singapore Series A, Series B, Series C Software, Artificial Intelligence, Biotechnology $3.4M–$44M
Shinhan Venture Investment
VC Fund
6 South Korea, United States, Japan Series B, Series A, Series C Biotechnology, Health Care, Software $2.2M–$71M
SBI Investment Korea
VC Fund
5 South Korea, United States, Japan Series A, Series B, Series C Information Technology, Artificial Intelligence, Software $2.5M–$33M
BNH Investment
VC Fund
5 South Korea Series B, Series A, Series C Biotechnology, Pharmaceutical, Medical $7k–$23M
Mirae Asset Capital
VC Fund
5 South Korea, United States, India Series B, Series A, Series C Health Care, Biotechnology, Artificial Intelligence $3M–$291M
L&S Venture Capital
VC Fund
5 South Korea, United States, Israel Series A, Series B, Seed Information Technology, Manufacturing, Software $600k–$39M
Korea Development Bank
VC Fund
5 South Korea, United States, China Series B, Series A, Series C Software, Information Technology, Artificial Intelligence $2.1M–$51M
Access all 695 VC funds in South Korea Biotechnology startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Dayli Partners
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 30 investments in South Korea Biotechnology startups

Dayli Partners is an investment firm.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, Indonesia

Investor stats

  • Total investments: 112
  • Round size: Seed $791k–$6.7M; Series A $839k–$17M; Series B $1.5M–$29M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Medifab — Medifab is a bio-healthcare center that offers 3D system testing, measurement analysis, and OEM service.
  • SN BioScience — SN BioScience provide nano-formulation screening services for small molecule, oligonucleotide (siRNA, DNA), peptide and protein to deliver in the form of nano-micelle, nanoparticle or liposome. Their proprietary “double core-shell technology” and pool of acceptable lipids and polymers could help your research that having difficulties in solubilityor delivery.
  • SureTech — Suretech is an AI insurtech firm, operates the Carsure platform, which automates the automotive insurance claims process from accident reporting to repair shop matching, cost estimation, and settlement.
Show all investments...

KB Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 20 investments in South Korea Biotechnology startups

Founded in 1990, KB Investment Co., Ltd. (KBIC) is one of Korea’s leading investment firms of venture capital and private equity funds with over USD 2.6 Billion of asset under management as of December 2023. KBIC is a subsidiary of KB Financial Group, Korea’s premier financial group with the largest domestic customer base as well as the widestnetwork of service branches in Korea.KBIC’s team is recognized for industry thought leadership, a broad network of powerful industry relationships, and a unique professional investment approach to investing. KBIC passionately support our portfolio companies with active guidance in all key aspects of team building, strategy, operations and governance

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, Vietnam

Investor stats

  • Total investments: 414
  • Round size: Seed $767k–$7.2M; Series A $2.1M–$36M; Series B $4.8M–$35M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • TESOLLO — TESOLLO develops robot and motion presenter products.
  • H&B Asia — H&B Asia specializes in sourcing, importing, and distributing fresh fruits and agricultural products. The company works closely with global growers and suppliers to bring high-quality produce into the Korean market. It focuses on building strong partnerships, ensuring consistent supply, and supporting efficient logistics across the fooddistribution value chain.
  • ACT-ion Battery Technologies — ACT-ion is pioneering a transformative approach to battery material manufacturing, specializing in advanced lithium battery cathode active materials (CAMs). Our innovative, clean, and efficient continuous process revolutionizes production, driving cost savings and enhanced performance for the energy
Show all investments...

Company K Partners
VC Fund · Ilsangu, Seoul-t'ukpyolsi, South Korea · 18 investments in South Korea Biotechnology startups, 18 in the past 12 months

Company K Partners Limited is a principal investment firm specializing in investments in culture content, electronic components, computer, machinery, broadcasting, arts, sports, and leisure industries. The firm primarily invests in South Korea with a focus in Seoul, Gyeongnam, and Gyeonggi. Company K Partners Limited was established in 2006 and isbased in Gyeonggi-do, South Korea.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Artificial Intelligence
  • Stage:Series A, Series B
  • Geography: South Korea, United States, Singapore

Investor stats

  • Total investments: 188
  • Round size: Series A $2.2M–$17M; Series B $6.5M–$42M
  • Lead/follow: 10% lead, 90% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • StepLab — StepLab is a microsatellite systems company specializing in space mechanism technology, developing innovative satellite platforms and advanced aerospace solutions that support efficient satellite deployment, in-orbit operations, and a wide range of commercial and scientific space missions.
  • EtherNafusion — EtherNafusion is an early-stage South Korean deep-tech startup developing compact modular nuclear fusion reactors.
  • Prazer Therapeutics — Prazer Therapeutics assists patients suffering from intractable diseases through the use of logical and innovative drug design approaches. They willaccomplished this through the use of new and innovative drug development platforms, such as rational molecular drug design technology and next-generation protein degradation technology.
Show all investments...

Industrial Bank of Korea
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 16 investments in South Korea Biotechnology startups

Industrial Bank of Korea (IBK) is committed to honoring its charter of financing small and medium sized enterprises (SMEs). The Bank has extended the scope of its expertise to provide a comprehensive range of financial services to individual customers in a quest to emerge as a leading financial services group. In pursuit of that goal, IBK is makingevery effort to enhance its competitiveness, achieve balanced growth and strengthen its global presence.The Bank employs around 10,000 staff and operates a distribution network of 612 branches including 12 overseas branches. Providing complementary services, the Bank also operates several subsidiaries: IBK Capital Corporation, IBK-SG Asset Management, IBK System Co., Ltd., and IBK Credit Information Corporation. In 2008, IBK Investment & Securities was launched, focused on meeting the needs of SME customers for services such as IPOs and M&As. Moreover, strategic alliance with Korea Investment Holdings enhances product competitiveness and affiliation with the National Post Office promoting easy customer access to IBK banking services.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, China

Investor stats

  • Total investments: 303
  • Round size: Seed $166k–$4.5M; Series A $2M–$17M; Series B $4.8M–$28M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Gadget Korea — Gadget korea offers data roaming services.
  • Flexell Space — FLEXELL SPACE primarily focuses on the development and manufacturing of space solar cells, aiming to provide differentiated products for our customers in the space industry
  • Raion Robotics — Raion Robotics manufactures walking robots for industrial applications and offers prospects in potential industries such as defense, construction, and logistics.
Show all investments...

Korea Investment Partners
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 14 investments in South Korea Biotechnology startups

Korea Investment Partners (KIP) is a leading venture capital & private equity firm that has over 30 years of experience in providing venture capital to bold and innovative entrepreneurs who want to change the world. Korea Investment Partners invests in leading pioneers like Kakao(KOSDAQ:035720), Naver(KRX:035420), YGEntertainment(KOSDAQ:122870), Bodyfriend, Osstem Implant(KOSDAQ:048260), Doubleu Games(KOSDAQ:192080) and Didi Chuxing. KIP manages over 20 venture and private equity funds with US$1.8 billion in total assets under management. The company operates globally from its Seoul headquarters office with other locations in Shanghai, Beijing, and Sunnyvale.

Show more...

Investment focus

  • Industry: Biotechnology, Information Technology, Health Care
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, China

Investor stats

  • Total investments: 474
  • Round size: Seed $1.2M–$10M; Series A $2.1M–$21M; Series B $4.7M–$52M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: May invest from a new fund soon — raised $6.7M in 2014

Portfolio highlights

  • Cashkaro — Cashkaro is an Indian cashback and coupons site. They are backed by Mr. Ratan Tata and Indian VC firms, Kalaari Capital. With over two million registered users, CashKaro is a one stop destination for savings across 1500+ ecommerce sites like Amazon.in, Flipkart, Nykaa, Ajio, etc.
  • Together Funding — Together Funding offers peer-to-peer financial service.
  • Inovio Pharmaceuticals — INOVIO is advancing novel immunotherapy technologies to reshape the future of treating and preventing infectious diseases and cancer.
Show all investments...

Mirae Asset Venture Investment
VC Fund · Seongnam, Kyonggi-do, South Korea · 12 investments in South Korea Biotechnology startups

Mirae Asset Venture Investment invests in specialized enterprises and provides technology, funding and management consulting.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, India

Investor stats

  • Total investments: 311
  • Round size: Seed $924k–$15M; Series A $1.9M–$38M; Series B $5M–$54M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • StepLab — StepLab is a microsatellite systems company specializing in space mechanism technology, developing innovative satellite platforms and advanced aerospace solutions that support efficient satellite deployment, in-orbit operations, and a wide range of commercial and scientific space missions.
  • Medifab — Medifab is a bio-healthcare center that offers 3D system testing, measurement analysis, and OEM service.
  • Ohouse — No.1 Interior Onestop Platform
Show all investments...

Aju IB Investment
VC Fund · Yeoksamdong, Seoul-t'ukpyolsi, South Korea · 12 investments in South Korea Biotechnology startups

Aju IB Investment is a venture capital firm that offers SMEs with investments and consulting services.Aju IB Investment offers consulting services that focus on business management, tax, accounting, legal, mergers and acquisitions, additional funding, marketing, and technology support.Aju IB Investment was founded in September 1974 and is basedin Seoul, South Korea.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 106
  • Lead/follow: no public data

Portfolio highlights

  • Gangnam Unni — Gangnam Unni is in the field of beauty medical services, helping users choose a treatment and a plastic surgery hospital. The difficulty of navigating the process of seeking medical treatment and choosing a hospital continues to persist. Kangnam Unni recognizes the need for change and firmly believes that a combination of transparent medicalinformation and an IT platform can foster a consumer-oriented medical service market. Their ultimate goal is to challenge negative perceptions surrounding plastic surgery and spearhead a significant transformation in the beauty and medical service industries.The Gangnam Unni team is dedicated to innovation, fueled by an unwavering desire to provide exceptional beauty and medical services. With the aim of assisting individuals in selecting a suitable hospital, they have amassed an impressive database of one million user reviews. Additionally, their efforts to promote transparency in medical information have garnered the support of 3,000 subscribers through Gangnam Sister. Furthermore, their mobile application has facilitated hospital consultations for a staggering 3.8 million individuals, resulting in 1.6 million successful cases.As the team continuously clarifies its mission and forges ahead with determination, its collective strength and resolve only grow stronger. Kangnam Unni remains committed to revolutionizing the healthcare industry, ensuring that individuals receive the highest quality of care and a positive experience throughout their medical journeys.
  • Healing Paper — Healing Paper is a mobile healthcare and information technology company.
  • Kovis Technology — Kovis Technology is a manufacturer of measurement and inspection equipment intended for global semiconductor and electronic industries.
Show all investments...

LSK Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 12 investments in South Korea Biotechnology startups

LSK Investment is a Korean venture capital firm that provides long-term capital and management support to venture enterprises. The firm was founded in 2016 and is based in Seoul, Korea.

Show more...

Investment focus

  • Industry: Biotechnology, Medical, Health Care
  • Stage:Series A, Series B, Series C
  • Geography: South Korea, United States

Investor stats

  • Total investments: 41
  • Round size: Series A $1.6M–$14M; Series B $7.4M–$16M; Series C $3.2M–$46M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Trioar — Trioar is a biotechnological research company that manufacture pharmaceutical products and drugs.
  • MBD — MBD is a biotechnology company that specializes in 3D cell culture platforms.
  • IMBiologics — IMBiologics is a biotechnology company that develops antibody-based drug candidates for diseases such as cancer and immune-related conditions. It conducts research and development using its own platforms to discover new therapeutic molecules.
Show all investments...

Kolon Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 11 investments in South Korea Biotechnology startups, 12 in the past 12 months

Kolon Investment, Inc. is a venture capital and private equity firm specializing in buyouts, mezzanine, corporate restructuring, growth capital, and turnaround investment. It prefers to invest in electronic components, petroleum, energy, computer, and telecommunications equipment. The firm primarily invests in South Korea with a focus in Seoul,Gyeonggi, Incheon, and Gyeongbuk. Kolon Investment, Inc. was established in 2000 and is based in Seoul, South Korea.Source: Businessweek

Show more...

Investment focus

  • Industry: Biotechnology, Software, Information Technology
  • Stage:Series A, Series B
  • Geography: South Korea, India, Indonesia

Investor stats

  • Total investments: 118
  • Round size: Series A $6k–$10M; Series B $4.8M–$24M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Nexusbe — Nexusbe is a manufacturer of atomic layer equipment technology intended to provide vacuum deposition equipment.
  • StepLab — StepLab is a microsatellite systems company specializing in space mechanism technology, developing innovative satellite platforms and advanced aerospace solutions that support efficient satellite deployment, in-orbit operations, and a wide range of commercial and scientific space missions.
  • The SMC Group — The SMC Group is a social marketing company.
Show all investments...

UTC Investment Co.
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 11 investments in South Korea Biotechnology startups

Since its incorporation in 1988, UTC Investment has been implementing and developing private equity investments with deep roots in buyout area, diversified human resources, and an impressive track record as a leading global investment firm.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 124
  • Round size: Series A $2.3M–$13M; Series B $4.9M–$21M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Beamworks — Beamworks is a research-centered company in medical imaging and conversational AI, that enables expert-level cancer diagnosis anywhere in the world and providing reliable medical consultations at any time. The company's platform utilizes an on-device AI system that processes ultrasound data in real-time without the need for serverconnectivity, achieving detection sensitivity and differential diagnosis performance, enabling healthcare providers to offer precise and timely diagnostics and improve patient outcomes, and reduce unnecessary procedures.
  • CanLab — CanLab is a developer of AI sensors that focuses on creating optical and thermal cameras, as well as real-time image processing platforms for ground, aerial, and marine mobility. Its product offerings include the Vision Camera, Edge AI Platform, Equipment for Thermal Cameras, and Automotive Camera MES.
  • AD System — AD System focuses on the development, manufacturing, sales and repairing of drones and other unmanned aerial vehicles.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Partners Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 11 investments in South Korea Biotechnology startups, 8 in the past 12 months

As a responsible and long-term partner, they aim to make various constructive contributions to portfolio companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series A, Series B, Series C
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 130
  • Round size: Series A $2.5M–$30M; Series B $5.5M–$98M; Series C $7.4M–$87M
  • Lead/follow: 12% lead, 88% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • XCENA — XCENA is a semiconductor company that develops data-centric computing systems designed for AI and large-scale data processing environments. The company builds computational memory technology that combines high-capacity pooled DDR5 memory with near-data processing capabilities, allowing computation to occur closer to where data is stored. Its coreplatform is based on the Compute Express Link (CXL) standard, which enables memory expansion beyond traditional CPU limitations while improving data movement efficiency and reducing latency in data center workloads. XCENA’s architecture is designed to support applications such as artificial intelligence workloads, vector databases, and large-scale analytics by addressing memory bandwidth and capacity constraints. The company provides a hardware-software ecosystem that includes computational memory systems and a full-stack software development kit. This SDK offers APIs, runtime tools, and drivers that allow applications to use computational memory without major changes to existing software architectures while also supporting low-level control for performance optimization.XCENA’s flagship product line includes MX1, a CXL-based computational memory solution that integrates near-data processing engines with memory infrastructure to support AI inference and data-intensive workloads. The platform is designed to improve throughput and scalability in environments where traditional memory architectures become a bottleneck. The company operates in the broader field of AI infrastructure and memory innovation, working with customers such as hyperscalers, telecom providers, and research institutions that manage large-scale computing workloads. Its solutions are intended to improve efficiency in systems handling AI, big data processing, and scientific computing.
  • Solivis — Solivis is the manufacturer of solid-state batteries designed for next-generation battery packs. The company's product is used as a secondary battery for electric vehicles and has developed a wet synthesis method that can mass-produce a sulfide-based solid electrolyte with homogeneous high ionic conductivity, enabling clients to significantlyimprove productivity by reducing process costs and shortening the synthesis time.
  • Cenyx Biotech — Cenyx Biotech develops diagnostic and therapeutic nano-compounds formed based on nanozymes and nanoparticles.
Show all investments...

Medytox Venture Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 11 investments in South Korea Biotechnology startups

Medytox Venture Investment is a TIPS operator that provides opportunities and supports growth in the healthcare sector.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Medical
  • Stage:Series A, Series B, Seed
  • Geography: South Korea

Investor stats

  • Total investments: 22
  • Round size: Seed $3M–$3.4M; Series A $3.4M–$15M; Series B $4k–$44M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Nex Eye — Nex Eye is an innovative biotechnology firm that offers revolutionary immunotherapy solutions for individuals battling cancer. The company addresses the fundamental reasons behind the failure of immunotherapy, which are influenced by the biology of cancer itself. Utilizing its ON-SMRT® platform based on actual patient data and resistant cancermodels, Nex Eye identifies new immune-evasion targets such as ONCOKINE®. By transforming the approach to tackling immune resistance, the firm is pioneering a new era in cancer therapy by revitalizing the capabilities of the immune system.
  • Dime Bio — Dime Bio is a drug development company for novel dementia treatments.
  • Inventera Pharmaceuticals — Inventera Pharmaceutical is a biotechnology company that specializes in the development of imaging diagnostic contrast agents.
Show all investments...

InfoBank
VC Fund · Gyeongju, Kyongsang-bukto, South Korea · 11 investments in South Korea Biotechnology startups

InfoBank develops and provides mobile messaging solutions and other related services.The company offers business messaging services such as SMS, LMS, and multimedia message services; interactive media services; smart car solutions; and integrated online and offline payment services.InfoBank was founded in 1995 and is based in Gyeongju, SouthKorea.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Information Technology, Software
  • Stage:Seed, Series A, Series B
  • Geography: South Korea, South Africa, United States

Investor stats

  • Total investments: 147
  • Round size: Seed $100k–$1.6M; Series A $761k–$9.4M; Series B $8M–$16M
  • Lead/follow: 27% lead, 73% follow

Portfolio highlights

  • A2D2 — A2D2 AI analyzes and organizes tens of thousands of pages of evidence documents.
  • All Conec — All Conec is a digital platform that connects dental clinics and laboratories around the world. The platform also provides dental equipment shopping. The user can plan implant surgery quickly and precisely through the platform.
  • Limpid — Limpid is a Bio pet food startup. It set new standards in pet nutrition through continuous innovation.
Show all investments...

STIC Ventures
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 10 investments in South Korea Biotechnology startups

STIC Ventures invests in small and mid-sized venture companies with core technologies and new business models.

Show more...

Investment focus

  • Industry: Biotechnology, Artificial Intelligence, Information Technology
  • Stage:Series A, Series B
  • Geography: South Korea, United States, Vietnam

Investor stats

  • Total investments: 130
  • Round size: Series A $2M–$44M; Series B $5.6M–$47M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Asteromorph — We are an AI for Science lab in Seoul. Our mission is to accelerate scientific advancements through the pursuit of superintelligence.
  • CYTUR — CYTUR is a leader in ship cyber security, support to shipowner and shipbuilder protect their smart-ships against cyber-attacks.
  • Pebble Square — Pebble Square's new Processing-In-Memory (PIM) architecture is a significant advancement for AI performance and power efficiency.
Show all investments...

Devsisters Ventures
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 10 investments in South Korea Biotechnology startups

Venture Capital firm in Korea. We are interested in early-stage investment in gaming, healthcare/biotech, IT services and high technology companies.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Gaming
  • Stage:Series A, Seed
  • Geography: South Korea, United States, Russian Federation

Investor stats

  • Total investments: 109
  • Round size: Seed $1k–$3.5M; Series A $1.4M–$8.2M
  • Lead/follow: 8% lead, 92% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Deeply — Deeply is a sound AI specialized in the unmanned surveillance industry. It also develops AI voice analysis technology designed to analyze non-verbal sounds and extract information. They serve city surveillance, infrastructure, military, rail, air, and port systems.
  • Red Brick House — Red Brick House is a specialized South Korean indie game publisher dedicated to discovering, supporting, and publishing innovative independent games, helping talented developers bring creative and engaging gaming experiences to players across domestic and global markets.
  • AWESOME Entertainment — AWESOME Entertainment is a media and digital content company that provides YouTube content production, influencer and MCN management, advertising and branded content creation, and media commerce services. The comapny supports brands with campaign planning, viral video production, and distribution across multiple social platforms, while alsooffering production outsourcing and partnership services to maximize audience reach and engagement.
Show all investments...

Series Ventures
VC Fund · Changwon, Kyongsang-namdo, South Korea · 9 investments in South Korea Biotechnology startups

Series Ventures is an investment company for the beauty care, engineering, healthcare, social platform, and enterprise sectors.

Show more...

Investment focus

  • Industry: Health Care, Manufacturing, Biotechnology
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: South Korea, Singapore

Investor stats

  • Total investments: 94
  • Round size: Seed $86k–$1.9M; Series A $2.9M–$4.4M
  • Lead/follow: 69% lead, 31% follow

Portfolio highlights

  • TouchMeal — TouchMind (operating as TouchMeal) runs an AI-driven senior foodtech platform that manages professional institutional catering, customized dietary meal planning, and automated ingredient supply chains for nursing homes. The company handles full kitchen management operations, including hygiene standards compliance, staff management, and thedistribution of specialized elderly-friendly food products.
  • HD Hi-Tech — HD Hi-Tech is an innovative technology company specializing in AI-powered switchboard safety diagnostic solutions, helping industries improve electrical system reliability, detect faults in real time, and enhance operational safety and efficiency.
  • ROBOS — Robos is a hybrid robot system built by evaluating biological object vision data using Lidar Vision and Open CV-based Object Detection. By combining self-developed biomaterial machine vision technology and robot technology, it intends to expand into a company that delivers core services to diverse industrial sites such as manufacturing, food, andmedical.
Show all investments...

Future Science and Technology Holdings
VC Fund · Daejeon, Taejon-jikhalsi, South Korea · 9 investments in South Korea Biotechnology startups

Future Science and Technology Holdings is an investment company that specializes in technology-based services.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Food and Beverage
  • Stage:Seed, Series A
  • Geography: South Korea, United States

Investor stats

  • Total investments: 34
  • Round size: Seed $223k–$1.7M; Series A $1.9M–$6.7M
  • Lead/follow: 29% lead, 71% follow

Portfolio highlights

  • Caretive
  • Protier Biotech — PROTIER Biotech is a company leading the development of therapeutics through innovative biotechnology .
  • ArcGen Bioscience — Embark on a Voyage in Immuno-Oncology
Show all investments...

Magna Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 9 investments in South Korea Biotechnology startups

As a Venture Capital / Accelerator / Private Equity Manager specialized in initial companies, SMEs and SMEs, They are generating profits by finding and investing in companies with promising growth potential.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Pharmaceutical
  • Stage:Seed, Series A, Series B
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 97
  • Round size: Seed $147k–$3M; Series A $1.5M–$12M; Series B $3.8M–$18M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • AIT STUDIO — AIT Studio is a digital health startup that develops AI-powered, contactless gait analysis solutions for early detection of mobility decline and age-related conditions such as sarcopenia. Our flagship products—GAIT Studio (App) and MediStep M Pro (hardware package)—deliver full gait assessments in under 1 minute, without wearables or specializedstaff.
  • Featuring — Featuring’s goal is to make it easy for anyone to see and utilize the power of influencers. Today, as companies are accelerating their transition to digital business due to COVID-19, the number of companies leveraging The number of influencers is explosively increasing. Featuring allows brands and marketers to discover product-fit influencers andhelps matching based on their needs. Currently, over 3,600 brands are using Featuring, and more than 8,500 influencer campaigns have been done. As a Korea-based startup, Featuring plans on expanding the business to Far East Asia, including Japan and China.
  • Endorobotics — Endorobotics is an educational technology company specializing in exam preparation solutions. Its platform provides automated question generation, adaptive difficulty adjustment, CSAT-style question modeling, and the creation of similar questions based on incorrect answers. The company enables middle and high school educators and students to accesspersonalized mock examinations, enhance learning outcomes, and streamline exam preparation through automation and data-driven insights.
Show all investments...

Enlight Ventures
VC Fund · 9 investments in South Korea Biotechnology startups, 11 in the past 12 months

Enlight Ventures, one of the fastest growing VCs in the world, invests in early-stage startups with unique and sustainable business models.

Show more...

Investment focus

  • Industry: Manufacturing, Information Technology, Artificial Intelligence
  • Stage:Seed, Series A, Series B
  • Geography: South Korea, Indonesia

Investor stats

  • Total investments: 87
  • Round size: Seed $392k–$3.3M; Series A $1.7M–$14M; Series B $2.7M–$20M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • TESOLLO — TESOLLO develops robot and motion presenter products.
  • Aigencore — Aigencore is a specialized, advanced technology company focused on tritium solutions, nuclear fusion fuel cycles, and tritium-applied industrial products.
  • Stress Solution — Based on unique medical and scientific information and ECG waveforms, Stress Solution creates sound that regulates and initiates the equilibrium of the autonomic nervous system. Currently, Healing Bit is utilizing wearable technology to detect stress in real time. Through this, an autonomous feedback system that uses artificial intelligence topredict individual stress level situations and take preventative measures is being developed.
Show all investments...

KB Securities
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 8 investments in South Korea Biotechnology startups, 13 in the past 12 months

KB Securities is a Financial Services company.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Series B, Series A, Venture - Series Unknown
  • Geography: South Korea, United States, China

Investor stats

  • Total investments: 155
  • Round size: Series A $2.4M–$12M; Series B $4.7M–$24M; Venture - Series Unknown $3.4M–$27M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Korean Air — Korean Air provides passenger air transportation, air cargo logistics, and related travel services through scheduled and charter flight operations. The company transports passengers between international and domestic destinations and manages ticketing, reservations, and in-flight services through its digital platforms and airport operations. Itscargo division handles freight transportation, including general cargo, special shipments, and charter logistics, and supports shipment tracking and electronic air waybill processing. The company also operates integrated logistics services such as trucking connections that link air routes with ground transport networks for cargo delivery. In addition, Korean Air runs programs that allow cargo customers to measure and reduce transportation-related carbon emissions through the use of sustainable aviation fuel initiatives.
  • Upstage — Upstage AI develops artificial intelligence technologies focused on large language models and document processing systems designed to support enterprise workflows. Its platform includes tools that convert unstructured data such as PDFs, scans, and emails into structured, machine-readable formats, enabling downstream analysis and automation. Thecompany also provides models like its Solar LLM, which are optimized for tasks such as text generation, information extraction, and question answering within business environments. Its solutions are applied across industries including finance, healthcare, insurance, and manufacturing to handle tasks like document parsing, data extraction, and workflow automation. Additionally, its services can be deployed through APIs, cloud environments, or on-premise systems to integrate with existing enterprise infrastructure.
  • Seeann Solution — integrated PSI manufacturer Seeann Solution
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Shinhan Capital
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 8 investments in South Korea Biotechnology startups

Shinhan Capital is a credit-specialized company offering corporate finance services for its clients. It provides financial services, lease, corporate loans, investment financing, housing loans, installment financing, etc. Shinhan Capital was established in 1991. The company is headquartered in Seoul, South Korea.

Show more...

Investment focus

  • Industry: Information Technology, Software, E-Commerce
  • Stage:Series A, Seed, Series B
  • Geography: South Korea, United States, India

Investor stats

  • Total investments: 193
  • Round size: Seed $347k–$4M; Series A $2.1M–$13M; Series B $3.7M–$18M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • Trioar — Trioar is a biotechnological research company that manufacture pharmaceutical products and drugs.
  • Nventric — Nventric is a medical device company that develops core products for neurovascular, coronary heart, and peripheral vascular applications.
  • KB-Element — KB-Element is a graphene development and production company that also turns graphene into intermediate items and novel materials.
Show all investments...

HB Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 8 investments in South Korea Biotechnology startups, 10 in the past 12 months

HB Investment Inc. was founded on November 11, 1999 starting with paid-in Capital of KRW 10 billion.Since its foundation, HB Investment Inc. has been investing small and medium businesses that have the potential for steady growth and profitability and helping the invested companies to grow well by giving various consulting services. As a result,HB Investment Inc.constructed comprehensive portfolio out of various industrial areas, such as game, entertainment, as well as representative high-tech industries related to semiconductor, Internet, LCD, and a smart phone, bio, health care. In addition, HB Investment Inc. has experiences in implementing business Success-fully by organizing several partnership funds for recent years.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Artificial Intelligence
  • Stage:Series B, Series A
  • Geography: South Korea, United States, Vietnam

Investor stats

  • Total investments: 149
  • Round size: Series A $1.5M–$8.9M; Series B $3.7M–$25M
  • Lead/follow: 8% lead, 92% follow

Portfolio highlights

  • Robros — Robros is constantly creating technology to break through the barrier between people and robots in order to build a world in which everyone in the service industry can live a physically and emotionally happy life.
  • Nventric — Nventric is a medical device company that develops core products for neurovascular, coronary heart, and peripheral vascular applications.
  • Destin Power — Destin Power manufactures power conditioning products designed to improve energy management and safety. The company created the ESS system by utilizing core power electronics technology such as control technology for energy storage systems, static and dynamic grid support technology, and micro-grid inverter technology.
Show all investments...

SJ Investment Partners
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 8 investments in South Korea Biotechnology startups

SJ Investment Partners is a venture capital firm that invests in the IT and biotechnology industries.

Show more...

Investment focus

  • Industry: Biotechnology, Manufacturing, Medical
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, Hong Kong

Investor stats

  • Total investments: 75
  • Round size: Seed $547k–$2.5M; Series A $1.5M–$12M; Series B $4M–$28M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • DevD — DevD is a startup that provides 1:1 customized content and recommendation services based on self-developed lifestyle AI algorithms.
  • Eleven O'Clock — Eleven O'Clock is a space management platform that offers non-face-to-face cleaning of accommodation facilities. The company's platform Keeper innovates space operation and management as the new standard for space management. The efficiency and quality of space management are improved according to the systematic manual of the Keeperplatform. The platform records and communicates every process as data, from management manuals to space status checks.
  • Real Estate Planet — Real Estate Planet is an AI-based real estate platform that provides transaction prices, investment, and management information.
Show all investments...

Timewise Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 7 investments in South Korea Biotechnology startups

TIMEWISE INVESTMENT, formerly known as CJ Venture Investment, is a principal investment firm specializing in investments in video broadcasting, animation, movies, culture contents, games, communications equipment, arts, sports, leisure, manufacturing and service, mobile devices and solutions, information technology, SI, web agency, cell therapy andbiotechnology sectors. The firm primarily invests in South Korea with a focus in Seoul, Gyeonggi, and Jeju. CJ Venture Investment was established in 2000 and is based in Seoul, South Korea.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Information Technology
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, Russian Federation

Investor stats

  • Total investments: 64
  • Round size: Seed $3k–$4.3M; Series A $3k–$8.7M; Series B $3M–$29M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Carlet Store — Carlet Bio is a wholesale supplier of packaging solutions.
  • Datumo — Datumo got your back!Obtaining the proper data has always been the top issue for many AI labs/companies. To solve this problem, Datumo provides a platform that connects your company to the crowd-workers.It's MORE than just a connection! We passionately research crowd-workers and your project to develop cutting-edge technologies forthe optimized mobile crowd-sourcing.Keep disrupting the world! Just for your project, we are here to maintain the quality, cost-efficiency, or any other burdens related to the data. Datumo was founded in 2018.
  • ProxiHealthcare USA — ProxiHealthcare USA is a biotechnology research focused personal and environmental healthcare organization.
Show all investments...

HG Initiative
VC Fund · Seongdong, Kyonggi-do, South Korea · 7 investments in South Korea Biotechnology startups

HGI runs an impact-driven business, seeking to address diverse social issues through sustainable innovations.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Seed, Series B
  • Geography: South Korea, United States

Investor stats

  • Total investments: 49
  • Round size: Seed $360k–$7.7M; Series A $1M–$8.2M; Series B $3.8M–$13M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • Brewguru — Brewguru is an online beverage store that makes and sells healthy beverages.
  • Lumora — Lumora is an Independent Power Producer (IPP) specializing in transforming idle land into renewable energy assets by developing, owning, and operating sustainable power generation projects that maximize land value while supporting clean energy production.
  • Dolbom-ui-sin — Caregiver is a specialized platform operator that provides hospitals with advanced nursing solutions, streamlining patient care coordination, enhancing clinical workflows, and supporting specialized nursing practices through intelligent tools and integrated digital systems.
Show all investments...

Timepolio Asset Management
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 7 investments in South Korea Biotechnology startups, 7 in the past 12 months

Timepolio Asset Management is an asset management firm.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Manufacturing
  • Stage:Series A, Series B, Series C
  • Geography: South Korea, United States, Russian Federation

Investor stats

  • Total investments: 74
  • Round size: Series A $2.4M–$17M; Series B $9k–$23M; Series C $10M–$80M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Meissa — Meissa is a drone-based construction tech startup that provides real-time 3D mapping and modeling. The company digitalizes sites with spatial data, such as design level comparison, and overlays floor plans collected by drone, as well as does three-dimensional modeling of projects, enabling companies to complete construction smartly.
  • The SMC Group — The SMC Group is a social marketing company.
  • Next Securities — The Next Generation AI-driven Brokerage Services
Show all investments...

BSK Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 7 investments in South Korea Biotechnology startups

BSK Investment is a private equity investment company that invests in unlisted companies.

Show more...

Investment focus

  • Industry: Biotechnology, Software, Health Care
  • Stage:Series A, Series B, Series C
  • Geography: South Korea

Investor stats

  • Total investments: 50
  • Round size: Series A $2.1M–$57M; Series B $4.8M–$26M; Series C $13M–$24M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • AITRICS — AITRICS delivers AI-powered medical software designed to support clinicians in detecting and preventing critical patient deterioration. The company’s core product, AITRICS‑VC (VitalCare), continuously monitors data from electronic medical records (EMRs), including vital signs, lab tests, consciousness levels, and other relevant clinicalmeasurements to predict adverse events such as sepsis, cardiac arrest, unexpected ICU transfers, or mortality several hours before they occur.AITRICS-VC operates in real time, delivering risk scores and alerts to clinicians to enable earlier intervention and better resource allocation in hospital settings. The platform has been certified by the relevant regulatory authority in its home country and is classified as an “innovative medical device,” reflecting regulatory recognition of its predictive-analytics capabilities. In addition to monitoring and prediction, AITRICS engages in ongoing clinical validation and research; it publishes studies in peer-reviewed journals and presents its work in international AI conferences, indicating a commitment to evidence-based development and transparency in performance.
  • FNCT Biotech — FNCT Biotech develops antibody therapeutics for treating idiopathic pulmonary fibrosis (IPF). To create antibodies that target the underlying cause of IPF, the company's platform uses genetic engineering, providing patients with this medical need with a new treatment option.
  • BOS Semiconductors — Driving the Future of Automotive, BOS Semiconductors
Show all investments...

Korea Technology Finance Corporation
VC Fund · Busan, Pusan-jikhalsi, South Korea · 7 investments in South Korea Biotechnology startups, 8 in the past 12 months

Korea Technology Finance Corporation is a South Korea-based fund for small and medium enterprises.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Medical
  • Stage:Seed, Series A, Series B
  • Geography: South Korea, Russian Federation

Investor stats

  • Total investments: 88
  • Round size: Seed $383k–$4.1M; Series A $1.4M–$7.4M; Series B $7k–$15M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • Leecell — Leecell is a solar cell manufacturing company that produces organic and perovskite thin‑film photovoltaic cells.
  • Elevenliter — Eleven Liter operates Lipet, an online health check solution for companion animals.
  • Intergravity — Intergravity is a company that is developing orbital transportation technologies to support the future of in-space activity. Intergravity is to enable a space environment in which mobility, service, and logistics are seamlessly integrated, creating the framework for long-term operations beyond Earth.
Show all investments...

Korea Credit Guarantee Fund
VC Fund · Daegu, Taegu-jikhalsi, South Korea · 7 investments in South Korea Biotechnology startups

Korea Credit Guarantee Fund operates as a public financial institution.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Information Technology, Software
  • Stage:Seed, Series A, Venture - Series Unknown
  • Geography: South Korea, United States, China

Investor stats

  • Total investments: 299
  • Round size: Seed $198k–$2.9M; Series A $786k–$7.8M; Venture - Series Unknown $884k–$15M
  • Lead/follow: 28% lead, 72% follow

Portfolio highlights

  • StepLab — StepLab is a microsatellite systems company specializing in space mechanism technology, developing innovative satellite platforms and advanced aerospace solutions that support efficient satellite deployment, in-orbit operations, and a wide range of commercial and scientific space missions.
  • Limpid — Limpid is a Bio pet food startup. It set new standards in pet nutrition through continuous innovation.
  • DoubleT — DoubleT is an innovative tech enterprise specialized in industrial workplace safety and business automation. Its premier product, HEIMDALL, utilizes artificial intelligence and real-time location systems to prevent industrial accidents. They also operate DoubleWorks for corporate management and Jikguraound to streamline global B2B sourcing forbusinesses.
Show all investments...

Stick Ventures
VC Fund · Seongnam, Kyonggi-do, South Korea · 7 investments in South Korea Biotechnology startups

Stick Ventures is a venture capital firm based in South Korea that prefers to invest in seed-stage, early-stage, and later-stage companies.

Show more...

Investment focus

  • Industry: Biotechnology, Artificial Intelligence, Health Care
  • Stage:Series B, Series A, Series C
  • Geography: South Korea, United States

Investor stats

  • Total investments: 51
  • Round size: Series A $2.3M–$12M; Series B $4M–$27M; Series C $16M–$122M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • HITS — HITS is a biotech company that creates digital solutions to accelerate drug development and introduce a new drug discovery paradigm. The company creates a cloud-based drug development platform that connects AI models with docking and molecular dynamics.
  • DeepMetrics — DeepMetrics is an AI-driven healthcare startup developing ICU automation solutions focused on mechanical ventilator control systems. The company uses machine learning and statistical data analysis to automatically optimize ventilator settings for critically ill patients. DeepMetrics operates in the digital health and medical AI sector.
  • Nobo Medicine — Nobo Medicine is a clinical-stage biotech company focused on developing precision therapies for blood cancers and immune-related aging diseases. It uses biomarker-driven drug discovery and translational research to identify targeted treatments, aiming to improve outcomes in oncology and age-associated immune dysfunction through innovative,data-driven biomedical approaches.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Dt& Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 7 investments in South Korea Biotechnology startups

Dt& Investment brings the spirit of Ubuntu to the world of Venture Capital.

Show more...

Investment focus

  • Industry: Biotechnology, E-Commerce, Health Care
  • Stage:Series B, Series A, Seed
  • Geography: South Korea, Vietnam, United States

Investor stats

  • Total investments: 62
  • Round size: Seed $2k–$4.5M; Series A $1.5M–$11M; Series B $2.7M–$18M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • Ettifos — Ettifos provides flexible, reliable, and innovative V2X solutions to enable communication between all stakeholders on the road.
  • Inocras — Unlock the potential of a Whole Genome Sequencing Test with Inocras. Transforming diagnosis and treatment for cancer and rare diseases.
  • HANCOM InSpace — Inspace is an aerospace and geospatial intelligence company specializing in satellite ground systems and AI-based Earth observation services. It develops platforms for processing and analyzing satellite, drone, SAR, optical, and infrared imagery to support defense, environment, and commercial monitoring applications. The company also provides droneoperation systems and space data solutions, turning complex geospatial data into actionable intelligence for government and enterprise users.
Show all investments...

IMM Investment
VC Fund · Kangnam, Cholla-namdo, South Korea · 7 investments in South Korea Biotechnology startups

Korean alternative asset investment firm

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Artificial Intelligence
  • Stage:Series A, Series B, Series C
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 266
  • Round size: Series A $3M–$55M; Series B $5.9M–$72M; Series C $7.7M–$46M
  • Lead/follow: 15% lead, 85% follow
  • Last fund: May invest from a new fund soon — raised $25M in 2016

Portfolio highlights

  • N.Light — N.Light is a Metaverse 3D design software that allows individuals to effortlessly turn their ideas into reality.
  • Ohouse — No.1 Interior Onestop Platform
  • ArcGen Bioscience — Embark on a Voyage in Immuno-Oncology
Show all investments...

Kiwoom Investment
VC Fund · Youidodong, Seoul-t'ukpyolsi, South Korea · 7 investments in South Korea Biotechnology startups, 12 in the past 12 months

Kiwoom Investment provides financial assistance with funding for small businesses.

Show more...

Investment focus

  • Industry: Information Technology, Software, Artificial Intelligence
  • Stage:Series B, Series A, Series C
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 110
  • Round size: Series A $1.7M–$14M; Series B $4.2M–$22M; Series C $11M–$33M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • Dnotitia — Dnotitia is a pioneering AI (Artificial Intelligence) company driving innovative value by integrating AI and data. Founded in October 2023, Dnotitia specializes in developing; Seahorse, a high-performance vector database powered by its proprietary Vector Data Processing Units (VDPU), and Mnemos, a cutting-edge service solution for Large LanguageModels (LLMs). The company also leads the development of sLMs (Small Language Models) and Retrieval-Augmented Generation (RAG) systems, crucial for advancing generative AI technologies and positioning itself at the forefront of AI technology.
  • MangoBoost — Data Processing Unit (DPU) is a next-generation server accelerator designed to orchestrate various intra-server devices (e.g., CPU, GPU, SSD, NPU, NIC). By maximizing the datacenter’s overall performance and cost efficiency, DPU is now considered as the most important HW/SW solution to realize the next-generation extreme-scale AI serverinfrastructure. However, despite its critical necessity from the datacenter and AI infrastructure, there is no market-leading DPU solution which can meet the customer’s actual demand due to its HW/SW complexity and the application/model heterogeneity. MangoBoost is currently the world’s most highly recognized DPU startup located in US and Korea. We provide the world’s most advanced and flexible DPU HW/SW solutions in order to fully satisfy the needs of various customers. Our DPU HW is fully composable by integrating its rich set of DPU features to construct our customer-optimal DPUs. At the same time, our DPU SW enables to seamlessly deploy the solution to any customer environment. As a result, our DPU solutions are considered very promising to realize the next-generation AI/datacenter infrastructure, and thus they are currently evaluated at various global-leading companies. MangoBoost was founded in early 2022 to commercialize 7 year of top-tier DPU research outcomes achieved at Seoul National University (e.g., many full-system DPU prototypes, many ISCA/MICRO/ASPLOS/OSDI/ATC papers). The current team consists of 45+ system engineers including ~20 top-tier PhDs from Carnegie Mellon University, Seoul National University, POSTECH, U Toronto, and ~20 industry experts from Intel, Microsoft, Samsung, and Naver.
  • Featuring — Featuring’s goal is to make it easy for anyone to see and utilize the power of influencers. Today, as companies are accelerating their transition to digital business due to COVID-19, the number of companies leveraging The number of influencers is explosively increasing. Featuring allows brands and marketers to discover product-fit influencers andhelps matching based on their needs. Currently, over 3,600 brands are using Featuring, and more than 8,500 influencer campaigns have been done. As a Korea-based startup, Featuring plans on expanding the business to Far East Asia, including Japan and China.
Show all investments...

Innopolis Partners
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 7 investments in South Korea Biotechnology startups

Innopolis Partners LLC. is a LLC-type venture capital firm in Korea. Partners of Innopolis Partners are former CEO or Representative Fund Manager of leading venture capital firms, such as Korea Technology Investment, STIC Investment, LG Venture Capital, KTB Network. “Innopolis No. 1 Fund” managed by Innopolis Partners is specialized for hi-techstartups in the Daedeok Innopolis complex. Daedeok Innopolis complex is set up based on former Daedeok R&D complex where most of major national R&D institutes, including ETRI, KAITST, KAERI, KRIBB, are located.

Show more...

Investment focus

  • Industry: Manufacturing, Health Care, Biotechnology
  • Stage:Series A, Seed
  • Geography: South Korea, United States, United Kingdom

Investor stats

  • Total investments: 108
  • Round size: Seed $1k–$11M; Series A $891k–$11M
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • EMX — emx is an artificial intelligence-based contents digital twin (CDT) & VFX team.
  • Arobot — Arobot creates robots with HRI-based behavior patterns, allowing consumers to embrace robots more readily and organically.
  • Cure Stream — CURESTREAM makes your day more free.
Show all investments...

ActnerLab
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 6 investments in South Korea Biotechnology startups

ActnerLab is a venture capital and accelerator that helps hardware, IoT and biotech startups establish their initial foothold and beyond.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Seed, Venture - Series Unknown
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 110
  • Round size: Seed $37k–$84k
  • Lead/follow: 4% lead, 96% follow

Portfolio highlights

  • C&SR — C&SR provides expertise in research and development necessary for navigating a drug candidate through humanized animal model making/testing.
  • Chain Lightning — Chain Lightning is an electric vehicle charging station that provides electric vehicle care payment and charge management services.
  • NAiEEL Technology — NAiEEL Technology offers energy and environmental technology solutions.
Show all investments...

Stonebridge Ventures
VC Fund · Thika, Central, Kenya · 6 investments in South Korea Biotechnology startups

Stonebridge Ventures was founded in 2008

Show more...

Investment focus

  • Industry: Artificial Intelligence, Biotechnology, Software
  • Stage:Series B, Series A, Seed
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 34
  • Round size: Seed $1M–$2.7M; Series A $736k–$14M; Series B $3.5M–$14M
  • Lead/follow: 26% lead, 74% follow

Portfolio highlights

  • Michelo Robotics — PORTAL301 is a tech startup focused on transforming the UI/UX in the robotics industry. It focus is on the nuclear power plant decommissioning and powder coating sectors.
  • Narnia Labs — Narnia Labs is the developer of artificial intelligence-based design software designed to provide domain-based three-dimensional synthetic data. The company's software provides design creation, evaluation, optimization, and recommendation services, enabling clients from engineering and industrial design fields to develop performance bycollaborating with AI, from manufacturing to architecture, medicine, and the metaverse.
  • Labrador Labs — LABRADOR LABS began as an academic research collaboration initiative to develop an automated analytic method for detecting both known and new vulnerabilities.
Show all investments...

Quad Asset Management
VC Fund · 6 investments in South Korea Biotechnology startups

Quad Asset Management is an Investment firm.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Medical
  • Stage:Series B, Series A, Series C
  • Geography: South Korea, United States

Investor stats

  • Total investments: 45
  • Round size: Series A $4.4M–$15M; Series B $4.5M–$42M; Series C $9.2M–$33M
  • Lead/follow: 2% lead, 98% follow

Portfolio highlights

  • Medifab — Medifab is a bio-healthcare center that offers 3D system testing, measurement analysis, and OEM service.
  • Nventric — Nventric is a medical device company that develops core products for neurovascular, coronary heart, and peripheral vascular applications.
  • Mediwhale — Mediwhale develops AI medical devices that analyze retinal images to predict cardiovascular, kidney, and eye disease risks early.
Show all investments...

Coolidge Corner Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 6 investments in South Korea Biotechnology startups

Coolidge Corner Investment (CCVC) provides Seed and Seed+ funding to the most innovative tech startup companies in Korea. They proudly provide their portfolio companies a customized support in professional incubating, growth hacking, strategy, network and more.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: South Korea, United States, Belgium

Investor stats

  • Total investments: 114
  • Round size: Seed $223k–$1.5M; Series A $891k–$5.4M; Series B $7.2M–$11M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • Frefins — Frefins is a specialized Rental Transformation (RX) company that generates value by connecting businesses, financial institutions, and consumers.
  • Plantner — PLANTNER develops environmentally friendly polymers that utilizes the controlled-release characteristics of alginate, a polymer derived from seaweed, along with natural controlled-release fertilizers to substitute current chemical products. Concurrently, the company is engaged in research and development as well as local field trials in Korea andVietnam. These innovations are directly aimed at promoting low-input sustainable agriculture. The organization is committed to tackling the unsustainable practices prevalent in conventional agriculture through the use of slow-release fertilizers, aspiring to foster eco-friendly advancements rooted in natural materials, beginning with agriculture, which is the cornerstone of the industry. In traditional agricultural settings, the significant loss of chemical fertilizers has resulted in nutrient depletion, leading to soil degradation issues such as acidification. This reduction in soil productivity compels farmers to resort to even greater quantities of chemicals to enhance yields, thereby perpetuating a detrimental cycle of increasing overuse. As a response, coated slow-release fertilizers have been introduced; however, their synthetic polymer coatings have contributed to the buildup of microplastics in the soil, harming the habitats of beneficial microorganisms and generating additional environmental challenges. To mitigate these concerns, ongoing research and development efforts are focused on substituting the conventional coating materials of slow-release fertilizers which are responsible for environmental issues like residual microplastics with alginate, a biodegradable polymer sourced from seaweed.
  • Partridge Systems — Partridge Systems develops an automotive data platform that enables real-time data transfer, sharing, and structured data management. The platform offers end-to-end capabilities, including data collection, storage, and deployment pipelines for processing vehicle big data through web-based visualization tools. It allows users to access streamingdata without local downloads and supports seamless collaboration among engineers worldwide.
Show all investments...

IBK Capital
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 6 investments in South Korea Biotechnology startups, 13 in the past 12 months

IBK Capital is the venture capital arm of the Industrial Bank of Korea (IBK).

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Information Technology
  • Stage:Series A, Seed, Series B
  • Geography: South Korea, United States, India

Investor stats

  • Total investments: 114
  • Round size: Seed $2k–$4M; Series A $1.5M–$9.8M; Series B $12k–$22M
  • Lead/follow: 5% lead, 95% follow

Portfolio highlights

  • MID — MID specializes in the development, testing, and production of space-related components.
  • FNCT Biotech — FNCT Biotech develops antibody therapeutics for treating idiopathic pulmonary fibrosis (IPF). To create antibodies that target the underlying cause of IPF, the company's platform uses genetic engineering, providing patients with this medical need with a new treatment option.
  • Automata — Automata builds ontology-driven enterprise systems that execute. Zenith verifies decisions, grades knowledge, and turns institutional memory into software you can run.
Show all investments...

Pathfinder H
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 6 investments in South Korea Biotechnology startups

Pathfinder H is a venture capital firm.

Show more...

Investment focus

  • Industry: E-Commerce, Biotechnology, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: South Korea

Investor stats

  • Total investments: 46
  • Round size: Seed $775k–$6M; Series A $3.3M–$13M; Series B $2.7M–$21M
  • Lead/follow: 7% lead, 93% follow

Portfolio highlights

  • Namdo Market — Namdo Market is a mobile application for wholesale and retail trading services. It is a online wholesale marketplace that connects buyers with products from major Korean shopping districts. It allows users to browse and order items directly from multiple vendors in one place.
  • Perseus — World Best Hypervisor Security Solutions for SDV
  • Camello Tech Co. — Camello Tech Co. is an agricultural products company that sells tea capsules and aloesonic pills.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Hana Ventures
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 6 investments in South Korea Biotechnology startups

Hana Ventures is a corporate venture capital of Hana Financial Group.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Health Care
  • Stage:Series A, Seed, Series B
  • Geography: South Korea, United States, Peru

Investor stats

  • Total investments: 215
  • Round size: Seed $253k–$4.5M; Series A $1.6M–$15M; Series B $3.7M–$42M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • BIGC — BIGC is a technology company that offers digital marketing, content creation, and advertising services.
  • Green Lamp — The Green Lamp Library is a study space dedicated to enhancing students' study efficiency and promoting the development of self-directed learning services through the implementation of gamification techniques to encourage engagement in learning. Among the standout features of the Green Lamp Library is the S2E (Study to Earn) system, whichincentivizes learning by enabling users to accumulate points that can be redeemed like cash through a variety of educational tasks. Additionally, it offers a structured system that assists users in concentrating on their studies for a predetermined duration.
  • Welcon Systems — WELCON Systems is a company that makes electronic control equipment used in machines. Their main products include servo drives and motion controllers, which help control the movement of motors in industrial machines and robots.
Show all investments...

POSCO CAPITAL
VC Fund · Yeoksamdong, Seoul-t'ukpyolsi, South Korea · 6 investments in South Korea Biotechnology startups, 9 in the past 12 months

POSCO Capital offers financial services.

Show more...

Investment focus

  • Industry: Software, Manufacturing, Information Technology
  • Stage:Series A, Seed, Series B
  • Geography: South Korea, United States

Investor stats

  • Total investments: 97
  • Round size: Seed $149k–$6.1M; Series A $1.2M–$10M; Series B $3.7M–$14M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Leecell — Leecell is a solar cell manufacturing company that produces organic and perovskite thin‑film photovoltaic cells.
  • MID — MID specializes in the development, testing, and production of space-related components.
  • Daedong Robotics — Daedong Robotics, a Daedong Group affiliate, offers AI robot solutions that understand agricultural sites, reducing time-consuming and hazardous tasks.
Show all investments...

Premier Partners
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 6 investments in South Korea Biotechnology startups, 13 in the past 12 months

Premier Partners (프리미어 파트너스) is a Korean domestic funds management company. It provides investment services for individuals and businesses. Premier Partners was established in September 2005 in Seoul, Korea.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Artificial Intelligence
  • Stage:Series B, Series A
  • Geography: South Korea, United States, Russian Federation

Investor stats

  • Total investments: 161
  • Round size: Series A $2.5M–$27M; Series B $5.8M–$45M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: Likely still investing — raised $82M in 2023

Portfolio highlights

  • FNCT Biotech — FNCT Biotech develops antibody therapeutics for treating idiopathic pulmonary fibrosis (IPF). To create antibodies that target the underlying cause of IPF, the company's platform uses genetic engineering, providing patients with this medical need with a new treatment option.
  • Prazer Therapeutics — Prazer Therapeutics assists patients suffering from intractable diseases through the use of logical and innovative drug design approaches. They willaccomplished this through the use of new and innovative drug development platforms, such as rational molecular drug design technology and next-generation protein degradation technology.
  • Akisostem BioStrategies — Archisostem BioStrategies is a research and development company.
Show all investments...

Atinum Partners
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 6 investments in South Korea Biotechnology startups

Atinum Partners is a venture capital firm that invests in the growth stage startups in the IT, biotech, and healthcare sectors.

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Biotechnology
  • Stage:Series A, Series B, Series C
  • Geography: South Korea, United States, Singapore

Investor stats

  • Total investments: 158
  • Round size: Series A $3.4M–$40M; Series B $5.8M–$44M; Series C $12M–$40M
  • Lead/follow: 28% lead, 72% follow

Portfolio highlights

  • AB180 — AB180 is a marketing technology company that develops software for app growth, user acquisition, engagement, attribution, and monetization. The company provides a full-stack AI platform that helps businesses measure marketing performance, optimize customer acquisition, improve user retention, and maximize revenue across mobile apps, games, anddigital services. Its product portfolio includes Airbridge, a mobile measurement partner (MMP) and attribution platform; DeepLink Plan, a deep linking and user journey optimization solution; and Airflux, an AI-powered monetization platform for mobile games. Together, these products enable businesses to measure cross-platform marketing performance, predict customer lifetime value (LTV), detect ad fraud, automate in-app advertising and purchase optimization, and deliver personalized user experiences.AB180 also provides AI-driven analytics, customer engagement, and marketing automation solutions that integrate with enterprise platforms and advertising ecosystems. Its technologies leverage machine learning to optimize marketing campaigns, improve conversion rates, automate monetization experiments, and generate actionable insights from user behavior. In addition to its proprietary products, the company is a strategic implementation and consulting partner for platforms such as Amplitude and Braze, helping organizations deploy and optimize data-driven growth strategies.
  • Modhaus — Modhaus is a K-pop startup which aims to create the world's first open architecture entertainment ecosystem.
  • Subtle Medical — Subtle Medical is a healthcare technology company that provides AI-powered medical imaging. Its products, SubtlePET and SubtleMR, are FDA Cleared and CE Marked AI product that enhances images in PET and MR exams aimed for faster & safer workflow.The company's SubtleGAD technology is also awarded by RSNA and a $1.6M NIH SBIR Grant tofacilitate the adoption using AI to make imaging exams safer. They provide a vendor-agnostic AI infrastructure powering its products and providing service and analytics to clinical imaging providers.Subtle Medical's goal is to improve the quality, value, and accessibility of medical imaging by significantly reducing cost, imaging time, and radiation dose.
Show all investments...

Shinhan Venture Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 6 investments in South Korea Biotechnology startups

Shinhan Venture Investment operates as an investment company. Shinhan Venture Investment focuses on earlier-stage venture capital investments and later-stage control investments opportunities derived from the latest megatrends such as the aging population, disruptive technologies, IT convergence, alternative energy and etc.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series A, Series C
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 209
  • Round size: Series A $2.2M–$26M; Series B $4.8M–$45M; Series C $7.6M–$71M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Nventric — Nventric is a medical device company that develops core products for neurovascular, coronary heart, and peripheral vascular applications.
  • Return Zero — AI, ASR, Diarization, Speech, ML
  • Linq — We are creating ‘hyper-automated insurance platforms’ to comprehensively support underwriters and claim adjusters and to facilitate communication between insurers and reinsurers using AI and deep learning.
Show all investments...

SBI Investment Korea
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 5 investments in South Korea Biotechnology startups, 8 in the past 12 months

SBI Investment Co., Ltd. has established itself as a true partner of the Republic of Korea venture business development in the past 28 years as a venture capital concept introduced first in Korea in 1986 was even unfamiliar concept of 'venture'. SBI Investment Co., Ltd. is a direct excavation domestic / other promising venturesinvestment as well as domestic / external funding attracted through cooperation with institutional investors and technology, marketing, public offering (IPO), the law, adhere to the role which has been providing comprehensive services such as Value-up tax.

Show more...

Investment focus

  • Industry: Information Technology, Artificial Intelligence, Software
  • Stage:Series A, Series B, Series C
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 117
  • Round size: Series A $2.5M–$15M; Series B $4.5M–$32M; Series C $8.5M–$33M
  • Lead/follow: 16% lead, 84% follow

Portfolio highlights

  • XCENA — XCENA is a semiconductor company that develops data-centric computing systems designed for AI and large-scale data processing environments. The company builds computational memory technology that combines high-capacity pooled DDR5 memory with near-data processing capabilities, allowing computation to occur closer to where data is stored. Its coreplatform is based on the Compute Express Link (CXL) standard, which enables memory expansion beyond traditional CPU limitations while improving data movement efficiency and reducing latency in data center workloads. XCENA’s architecture is designed to support applications such as artificial intelligence workloads, vector databases, and large-scale analytics by addressing memory bandwidth and capacity constraints. The company provides a hardware-software ecosystem that includes computational memory systems and a full-stack software development kit. This SDK offers APIs, runtime tools, and drivers that allow applications to use computational memory without major changes to existing software architectures while also supporting low-level control for performance optimization.XCENA’s flagship product line includes MX1, a CXL-based computational memory solution that integrates near-data processing engines with memory infrastructure to support AI inference and data-intensive workloads. The platform is designed to improve throughput and scalability in environments where traditional memory architectures become a bottleneck. The company operates in the broader field of AI infrastructure and memory innovation, working with customers such as hyperscalers, telecom providers, and research institutions that manage large-scale computing workloads. Its solutions are intended to improve efficiency in systems handling AI, big data processing, and scientific computing.
  • Automata — Automata builds ontology-driven enterprise systems that execute. Zenith verifies decisions, grades knowledge, and turns institutional memory into software you can run.
  • Cenyx Biotech — Cenyx Biotech develops diagnostic and therapeutic nano-compounds formed based on nanozymes and nanoparticles.
Show all investments...

BNH Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 5 investments in South Korea Biotechnology startups, 7 in the past 12 months

BNH Investment is an investment company for bio and healthcare sectors.

Show more...

Investment focus

  • Industry: Biotechnology, Pharmaceutical, Medical
  • Stage:Series B, Series A, Series C
  • Geography: South Korea

Investor stats

  • Total investments: 39
  • Round size: Series A $7k–$9.3M; Series B $7.3M–$20M; Series C $8.2M–$23M
  • Lead/follow: 10% lead, 90% follow

Portfolio highlights

  • ENCell — ENCell is a biotech company that develops and manufactures biopharmaceuticals.
  • Mustbio — MustBio is a biotechnology company that leverages multi-antibody technology to develop therapeutics primarily in the field of immuno-oncology. The company was founded in 2021 and is based in Seoul, South Korea.
  • LabInCube — LabInCube develops inCube materials capable of selective drug release, sustained release, and supporting complex raw materials.
Show all investments...

Mirae Asset Capital
VC Fund · Mumbai, Maharashtra, India · 5 investments in South Korea Biotechnology startups

Mirae Asset Capital Market is a leading global investment banking, securities and institutional business firm that provides a wide range of financial services to a substantial and diversified client base.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Artificial Intelligence
  • Stage:Series B, Series A, Series C
  • Geography: South Korea, United States, India

Investor stats

  • Total investments: 140
  • Round size: Series A $3M–$47M; Series B $7.5M–$105M; Series C $22M–$291M
  • Lead/follow: 11% lead, 89% follow

Portfolio highlights

  • Medifab — Medifab is a bio-healthcare center that offers 3D system testing, measurement analysis, and OEM service.
  • Flexell Space — FLEXELL SPACE primarily focuses on the development and manufacturing of space solar cells, aiming to provide differentiated products for our customers in the space industry
  • Ohouse — No.1 Interior Onestop Platform
Show all investments...

L&S Venture Capital
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 5 investments in South Korea Biotechnology startups, 6 in the past 12 months

L&S Venture Capital is a venture capital firm. L&S Venture Capital is specializing in incubation, seed, early, and expansion stage investments. L&S Venture Capital invests in electronic components, including smart phones, pads, televisions and grid; telecommunications equipments; green energy sector, such as solar, wind, fuel cell, LED,and EV; machineries; broadcasting; nanotechnology; intelligent robotics; telematics; medical equipments; media contents, which inlcude creation, distribution and new media. L&S Venture Capital primarily invests in South Korea with a focus in Seoul, Gyeonggi region, and Chungnam province. L&S Venture Capital was founded in 2006 and is based in Seoul, South Korea.

Show more...

Investment focus

  • Industry: Information Technology, Manufacturing, Software
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, United States, Israel

Investor stats

  • Total investments: 113
  • Round size: Seed $600k–$5.1M; Series A $1.9M–$8.8M; Series B $4.8M–$39M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Uniqconn — Uniqconn is a telecommunication company that offers wireless and mechanical interference services.
  • Awexome Ray — Awexome Ray is a company that manufactures next-generation X-ray generator.
  • Flexell Space — FLEXELL SPACE primarily focuses on the development and manufacturing of space solar cells, aiming to provide differentiated products for our customers in the space industry
Show all investments...

Korea Development Bank
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 5 investments in South Korea Biotechnology startups

The Korea Development Bank (KDB) provides long-term financing for projects designed to assist Koreaâ€:tm:s economic growth and development. It offers equipment capital loans and working capital loans to Korean private enterprises that undertake major industrial projects. The bank also extends guarantees to its clients to facilitate their otherborrowings and to finance major industrial projects. KDB guarantees Won-denominated corporate debentures, local currency loans, and other Won liabilities and foreign currency loans from domestic and overseas Korean financial institutions and from foreign institutions. The bankâ€:tm:s other activities include engagement in a range of industrial development activities, including conducting economic and industrial research; performing engineering surveys; providing business analyses and managerial assistance; and offering trust services. As of June 30, 2007, KDB had 40 local branches, 6 overseas branches, and 2 overseas offices. The bank was founded in 1954 and is headquartered in Seoul, South Korea.

Show more...

Investment focus

  • Industry: Software, Information Technology, Artificial Intelligence
  • Stage:Series B, Series A, Series C
  • Geography: South Korea, United States, China

Investor stats

  • Total investments: 336
  • Round size: Series A $2.1M–$32M; Series B $5.1M–$33M; Series C $7.5M–$51M
  • Lead/follow: 14% lead, 86% follow

Portfolio highlights

  • N.Light — N.Light is a Metaverse 3D design software that allows individuals to effortlessly turn their ideas into reality.
  • Flexell Space — FLEXELL SPACE primarily focuses on the development and manufacturing of space solar cells, aiming to provide differentiated products for our customers in the space industry
  • READi Robust Machine — Ready Robust Machine is a company that makes carbon reduction and fuel cost improvement systems.
Show all investments...

Biotechnology VC funding in South Korea at a glance

Stats across 905 deals from 695 investors.

695
investors
in South Korea Biotechnology startups
905
deals
in South Korea Biotechnology startups
$5.3M
median round
in South Korea Biotechnology startups
30%
lead investors
lead at least one round
21%
Seed
most common funding stage

Access all 695 VC funds in South Korea Biotechnology startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Biotechnology VC Funds in South Korea investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 695 VC funds investing in South Korea Biotechnology startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists